Inclusion body myositis with human immunodeficiency virus infection: Four cases with clonal expansion of viral‐specific T cells

Sporadic inclusion body myositis (sIBM), a common adult‐onset myositis, is characterized by an antigen‐driven inflammatory response and vacuolar degeneration. The cause is unknown. We report the association of sIBM with human immunodeficiency virus (HIV) infection and explore the clonality and viral specificity of the autoinvasive T cells.

[1]  E. Hoffman,et al.  Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. , 2005, Arthritis and rheumatism.

[2]  M. Weller,et al.  Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies. , 2003, Brain : a journal of neurology.

[3]  M. Dalakas,et al.  Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.

[4]  M. Loutfy,et al.  Inclusion body myositis: another possible manifestation of antiretroviral-associated mitochondrial toxicity. , 2003, AIDS.

[5]  C. Larsen,et al.  Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders. , 1985, Virology.

[6]  M. Buchmeier,et al.  The virology and immunobiology of lymphocytic choriomeningitis virus infection. , 1980, Advances in immunology.

[7]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[8]  M. Dalakas.  Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.

[9]  J. Keene,et al.  A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30 gag antigen , 1987, Cell.

[10]  Reinhard Hohlfeld,et al.  T-cell heterogeneity in muscle lesions of inclusion body myositis , 1998, Journal of Neuroimmunology.

[11]  M. Dalakas,et al.  Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis , 1993, Muscle & nerve.

[12]  S M Chou,et al.  Myxovirus-Like Structures in a Case of Human Chronic Polymyositis , 1967, Science.

[13]  J. Schröder,et al.  Differential expression of chemokines in inflammatory myopathies , 2002, Neurology.

[14]  J. Verschuuren,et al.  Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis , 2004, Neurology.

[15]  A. Gessain,et al.  Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J Miller,et al.  Inclusion body myositis in HIV-1 and HTLV-1 infected patients. , 1996, Brain : a journal of neurology.

[17]  J. Mikol,et al.  Inclusion‐body myositis: Clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen , 1982, Annals of neurology.

[18]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[19]  A. Engel,et al.  Inclusion body myositis: The mumps virus hypothesis , 1989, Annals of neurology.

[20]  M. Dalakas,et al.  Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies , 2006, Nature Clinical Practice Neurology.

[21]  M. Dalakas,et al.  Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis , 1998, Muscle & nerve.

[22]  M. Dalakas,et al.  Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies. , 2000, Brain : a journal of neurology.

[23]  A. Oldfors,et al.  Inclusion Body Myositis: Clonal Expansions of Muscle‐Infiltrating T Cells Persist Over Time , 2003, Scandinavian journal of immunology.

[24]  S. M. Chou,et al.  Inclusion body myositis: a chronic persistent mumps myositis? , 1986, Human pathology.

[25]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[26]  M. Dalakas,et al.  Immunocytochemical and virological characteristics of hiv‐associated inflammatory myopathies: Similarities with seronegative polymyositis , 1991, Annals of neurology.

[27]  Richard J. Barohn,et al.  Inclusion body myositis , 2000, Current treatment options in neurology.

[28]  M. Dalakas,et al.  Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. , 2004, Brain : a journal of neurology.

[29]  M. Dalakas,et al.  Expression of IFN-γ-inducible chemokines in inclusion body myositis , 2003, Journal of Neuroimmunology.

[30]  M. Dalakas,et al.  Polymyositis inpatients infected with human T‐cell leukemia virus type I: The role of the virus in the cause of the disease , 1994, Annals of neurology.

[31]  Pietro Fratta,et al.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. , 2005, The American journal of pathology.

[32]  A. Gessain,et al.  Direct Evidence for a Chronic CD8+-T-Cell-Mediated Immune Reaction to Tax within the Muscle of a Human T-Cell Leukemia/Lymphoma Virus Type 1-Infected Patient with Sporadic Inclusion Body Myositis , 2004, Journal of Virology.

[33]  R. Horton,et al.  Designing PCR primers to amplify specific members or subgroups of multigene families. , 1997, Methods in molecular biology.

[34]  T. Wileman.  Aggresomes and Autophagy Generate Sites for Virus Replication , 2006, Science.

[35]  W. Engel,et al.  Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-&bgr;, misfolded proteins, predisposing genes, and aging , 2003, Current opinion in rheumatology.

[36]  M. Dalakas,et al.  Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.

[37]  M. Dalakas,et al.  Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. , 1999, The American journal of pathology.

[38]  D. Figarella-Branger,et al.  Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies , 2003, Muscle & nerve.

[39]  L. V. Van Eldik,et al.  Increased susceptibility of S100B transgenic mice to perinatal hypoxia‐ischemia , 2004, Annals of neurology.

[40]  S. Izumo,et al.  Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. , 2002, The Journal of infectious diseases.